Nephrocare Health Services Limited
Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Revenue grew 24.8% YoY
Concerns1
- Low return on equity of 1.0%
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 5 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ544.00 Cr | β | βΉ34.00 Cr | β | β | 6.3% | 24.8% | 750.0% |
| Mar 2024 | βΉ436.00 Cr | β | βΉ4.00 Cr | β | β | 1.0% | 13.0% | -126.7% |
| Mar 2023 | βΉ386.00 Cr | β | βΉ-15.00 | β | β | -3.8% | 21.8% | -31.8% |
| Mar 2022 | βΉ317.00 Cr | β | βΉ-22.00 | β | β | -5.4% | 11.6% | -2300.0% |
| Mar 2021 | βΉ284.00 Cr | β | βΉ1.00 Cr | β | β | 0.4% | β | β |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | Mar 2025 |
|---|---|
| Revenue / Net Sales | 544 |
| Total Expenses | 449 |
| EBIT / Operating Profit | 95 |
| OPM % | 17% |
| Other Income | 16 |
| Finance Costs | 14 |
| Depreciation & Amortisation | 51 |
| Profit Before Tax | 45 |
| Tax % | 25% |
| Net Profit / PAT | 34 |
| EPS (βΉ) | 164.24 |
| Dividend Payout % | 0% |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Nephrocare Health Services Limitedthis co. | βΉ4.82 K Cr | βΉ544.00 Cr | 141.00 | 0.00 | 82.29 | 24.8% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |